Dr. Jahan Joyce Mohiuddin, MD

Dr. Mohiuddin practices at Matthews Radiation Oncology Center in Charlotte, North Carolina.

Dr. Mohiuddin's NPI, 1093177727, was assigned on March 22, 2016. Dr. Mohiuddin holds North Carolina license 269136.

Dr. Mohiuddin's primary practice is Matthews Radiation Oncology Center, at 200 Queens Rd, Charlotte, NC 28204 in Mecklenburg County. The practice phone is (704) 845-8800.

Dr. Mohiuddin's primary practice is Matthews Radiation Oncology Center in Charlotte, North Carolina. Dr. Mohiuddin is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is SERO (Southeast Radiation Oncology Group). Dmand AI also links Dr. Mohiuddin to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mohiuddin practices, 8 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Mohiuddin's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mohiuddin is licensed in North Carolina.

CMS data shows 4,331 Medicare services from Dr. Mohiuddin across 24 procedure codes in 2024, for 473 Medicare patients. Medicare paid $754,351 for them.

CMS counts 473 Medicare patients who saw Dr. Mohiuddin in 2024. The largest group is 65 to 74, with 228 patients. 75% of them have cancer, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mohiuddin's median patient age at 71, with 48% women.

In 2024, Dr. Mohiuddin wrote 92 Medicare Part D claims for 58 patients. 89% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $95 in total drug cost. In 2023, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mohiuddin for performance year 2024, reported as part of a group. Dr. Mohiuddin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mohiuddin as offering telehealth.

Dmand AI links 15 papers to Dr. Mohiuddin, published from 2013 to 2023. 2013 was the busiest year, with 2. The most frequent topics are Prostatic Neoplasms, Radiotherapy Dosage and Androgen Antagonists. Dr. Mohiuddin has published most often in Cancer. Dr. Mohiuddin's most frequent co-authors are Ronald C. Chen, MD, John N. Lukens, MD and Ravi K. Amaravadi, MD.

CMS Open Payments shows 2 general payments to Dr. Mohiuddin from 2 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $96.